Core B: Molecular Pathology and Bioinformatics Core
- Institution
- SLOAN-KETTERING INST CAN RESEARCH, NY
- Principal investigator
- Michael F. Berger
- Funding
- $698K
- Duration
- 2024–2029
Moonbase score
Still being scored
Abstract
CORE B ABSTRACT Molecular Pathology and Bioinformatics Core Core Director: Michael Berger, PhD (MSK) The Molecular Pathology and Bioinformatics Core will work closely with all Project teams to coordinate the procurement and analysis of patient-derived tumor and matched normal tissue prioritized for further characterization to fulfill the Research Aims. Biospecimens from selected patients will be obtained from participating AACR GENIE sites and characterized centrally by the Core. Digital pathology imaging and nucleic acid extraction will be performed from FFPE tissue specimens using standardized protocols. Comprehensive genomic platforms, including whole exome sequencing and RNA-Seq, will be run under the direct supervision of the Core Director to enable deeper, multi-omic characterization of samples previously tested using targeted DNA panels. State-of-the-art bioinformatics pipelines will be used to produce and disseminate results to Project teams, and Core members will collaborate with each Project to provide customized analytics support directed to the individual Aims.
LOADING MOONBASE SCORE
Questions for SLOAN-KETTERING INST CAN RESEARCH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Sloan-Kettering Inst Can ResearchNot yet scored
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Michael F. Berger · $735K · 2022–2027
- NIH · Sloan-Kettering Inst Can ResearchNot yet scored
MSK Computational Biology Summer Program
Michael F. Berger · $288K · 2019–2029
- NIH · Sloan-Kettering Inst Can Research60
Expansion of Tumoroid Models for Precise Treatment of the Rectal Cancer Patient
Jesse Joshua Smith · $80K · 2025